methotrexate has been researched along with Growth Disorders in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (17.39) | 18.7374 |
| 1990's | 10 (43.48) | 18.2507 |
| 2000's | 6 (26.09) | 29.6817 |
| 2010's | 2 (8.70) | 24.3611 |
| 2020's | 1 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Harjaček, M; Lamot, L; Smajo, A; Vidović, M; Vukić, V; Vukojević, R | 1 |
| Kim, HS; Kim, JY; Park, SH | 1 |
| Boros, C; Whitehead, B | 1 |
| O'Meara, P; Stanford, M; Wheeler, M | 1 |
| Ahmed, SF; Hassan, K; McGrogan, P; Weaver, LT; Wong, SC | 1 |
| Battin, M; Chessells, J; Christie, D; Leiper, AD; Neville, BG; Vargha-Khadem, F | 1 |
| Groot-Loonen, JJ; Lippens, RJ; Otten, BJ; Stoelinga, GB; van t' Hof, MA | 1 |
| Chessells, JM | 1 |
| Howes, A; Landy, H; Mullenix, PJ; Schunior, A; Tarbell, NJ; Zengel, AE | 1 |
| de Muinck Keizer-Schrama, SM; Drop, SL; Hählen, K; Hokken-Koelega, AC; Stijnen, T; van Doorn, JW | 1 |
| Garwicz, S; Moëll, C | 1 |
| Benaim, E; Crist, WM; Hudson, MM; Liu, Q; Pui, CH; Ribeiro, RC; Rivera, GK | 1 |
| Aumann, V; Dörffel, W; Kluba, U; Mittler, U; Mohnike, K; Timme, J; Vorwerk, P | 1 |
| Bennett, FC; Del Campo, M; Jones, KL; Kosaki, K | 1 |
| Akiyoshi, K; Eguchi, H; Hara, T; Inada, H; Ishii, E; Koga, H; Matsuzaki, A; Miyazaki, S; Nagatoshi, Y; Nakayama, H; Nibu, K; Okamura, J; Take, H; Tamai, Y; Yanai, F | 1 |
| Baldassano, R; Batres, LA; Ng, D; Stephens, M | 1 |
| Iqbal, MP; Mehboobali, N; Pervez, S; Sultana, F | 1 |
| Helin, P; Jacobsen, GK; Matthiesen, G; Nielsen, NS; Pedersen, VF | 1 |
| Becker, MH; Converse, JM; Cox, RP; Genieser, NB; McCarthy, JG; Reich, EW | 1 |
| Iwai, A; Komazawa, M; Maeda, H; Nagata, K; Ninomiya, T; Nishikawa, K; Ohmiya, A; Ohta, M; Sato, J; Tsuda, Y | 1 |
| Garwicz, S; Moëll, C; Westgren, U; Wiebe, T | 1 |
| Bessho, F | 1 |
| Miescher, PA; Schrago, R | 1 |
4 review(s) available for methotrexate and Growth Disorders
| Article | Year |
|---|---|
Juvenile idiopathic arthritis.
Topics: Adrenal Cortex Hormones; Age Factors; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Juvenile; Australia; Diagnosis, Differential; Growth Disorders; Humans; Methotrexate; Practice Guidelines as Topic; Risk Assessment; Uveitis | 2010 |
Central nervous system directed therapy in acute lymphoblastic leukaemia.
Topics: Adrenal Cortex Hormones; Adult; Child; Clinical Trials as Topic; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Female; Growth Disorders; Humans; Injections, Spinal; Leukemic Infiltration; Male; Meninges; Mental Disorders; Methotrexate; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Quality of Life; Radiation Injuries; Risk Factors; Survival Rate; Survivors; Treatment Outcome | 1994 |
Developmental delay in fetal aminopterin/methotrexate syndrome.
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Adult; Aminopterin; Child, Preschool; Developmental Disabilities; Face; Female; Folic Acid Antagonists; Growth Disorders; Humans; Intellectual Disability; Limb Deformities, Congenital; Male; Methotrexate; Pregnancy; Syndrome | 1999 |
Long-term outcome of treatment with protocols AL841, AL851, and ALHR88 in children with acute lymphoblastic leukemia: results obtained by the Kyushu-Yamaguchi Children's Cancer Study Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Body Height; Body Weight; Child; Child, Preschool; Clinical Trials as Topic; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Growth Disorders; Heart Failure; Hematopoietic Stem Cell Transplantation; Humans; Infant; Japan; Male; Methotrexate; Myelodysplastic Syndromes; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Rate; Survivors; Treatment Outcome; Vincristine | 2001 |
19 other study(ies) available for methotrexate and Growth Disorders
| Article | Year |
|---|---|
Beyond the guidelines management of juvenile idiopathic arthritis: a case report of a girl with polyarticular disease refractory to multiple treatment options and Leri Weill syndrome.
Topics: Adolescent; Antirheumatic Agents; Arthritis, Juvenile; Child; Female; Growth Disorders; Humans; Methotrexate; Osteochondrodysplasias | 2021 |
Disease flare after 7 year-remission of systemic type juvenile idiopathic arthritis: is growth hormone therapy a culprit or innocent bystander?
Topics: Administration, Oral; Adolescent; Antirheumatic Agents; Arthritis, Juvenile; Drug Therapy, Combination; Glucocorticoids; Growth Disorders; Human Growth Hormone; Humans; Male; Methotrexate; Recurrence; Remission Induction; Risk Factors; Time Factors; Treatment Outcome | 2015 |
Fetal methotrexate and misoprostol exposure: the past revisited.
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Abortifacient Agents, Nonsteroidal; Abortion, Incomplete; Abortion, Induced; Adult; Female; Growth Disorders; Humans; Infant; Methotrexate; Misoprostol; Pregnancy | 2002 |
The effects of recombinant human growth hormone on linear growth in children with Crohn's disease and short stature.
Topics: Administration, Oral; Adolescent; Age Determination by Skeleton; Age Factors; Antibodies, Monoclonal; Body Height; C-Reactive Protein; Child; Crohn Disease; Dose-Response Relationship, Drug; Glucocorticoids; Growth Disorders; Human Growth Hormone; Humans; Infliximab; Injections, Subcutaneous; Male; Methotrexate; Physical Examination; Puberty; Recombinant Proteins; Retrospective Studies; Serum Albumin; Time Factors; Treatment Outcome | 2007 |
Neuropsychological and neurological outcome after relapse of lymphoblastic leukaemia.
Topics: Age Factors; Brain; Child; Child, Preschool; Cognition Disorders; Cranial Irradiation; Developmental Disabilities; Education; Female; Growth Disorders; Humans; Infant; Intelligence; Leukemia, Lymphoid; Leukemic Infiltration; Male; Methotrexate; Nervous System Diseases; Radiation Injuries; Radiotherapy; Recurrence; Whole-Body Irradiation | 1994 |
Chemotherapy plays a major role in the inhibition of catch-up growth during maintenance therapy for childhood acute lymphoblastic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Growth; Growth Disorders; Humans; Infant; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1995 |
Radiation effects on growth are altered in rats by prednisone and methotrexate.
Topics: Animals; Behavior, Animal; Body Weight; Cephalometry; Cranial Irradiation; Drug Therapy, Combination; Female; Growth Disorders; Male; Methotrexate; Prednisolone; Radiation Injuries, Experimental; Rats; Rats, Sprague-Dawley; Skull; Specific Pathogen-Free Organisms | 1994 |
Long-term effects of treatment for acute lymphoblastic leukemia with and without cranial irradiation on growth and puberty: a comparative study.
Topics: Adolescent; Body Height; Brain; Child; Child, Preschool; Combined Modality Therapy; Female; Growth; Growth Disorders; Humans; Infant; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Puberty | 1993 |
High-dose methotrexate causes short-term suppression of growth in rabbits.
Topics: Animals; Antineoplastic Agents; Bone and Bones; Bone Development; Dose-Response Relationship, Drug; Growth Disorders; Methotrexate; Rabbits; Radiography | 1995 |
Effectiveness of intensified rotational combination chemotherapy for late hematologic relapse of childhood acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Disease-Free Survival; Drug Administration Schedule; Female; Growth Disorders; Humans; Hydrocortisone; Leukemic Infiltration; Life Tables; Male; Meninges; Methotrexate; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Proportional Hazards Models; Prospective Studies; Remission Induction; Salvage Therapy; Survival Analysis; Survival Rate; Teniposide; Testis; Time Factors; Treatment Outcome; Vincristine | 1996 |
Final height and puberty in 40 patients after antileukaemic treatment during childhood.
Topics: Adolescent; Age Factors; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Combined Modality Therapy; Cranial Irradiation; Dose-Response Relationship, Radiation; Female; Growth; Growth Disorders; Humans; Longitudinal Studies; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Puberty | 1997 |
Growth failure in the child with inflammatory bowel disease.
Topics: Adolescent; Antibodies, Monoclonal; Antimetabolites, Antineoplastic; Biopsy; Bone Density; Child; Colonoscopy; Crohn Disease; Female; Gastrointestinal Agents; Growth Disorders; Humans; Inflammatory Bowel Diseases; Infliximab; Male; Methotrexate | 2001 |
Folinic acid protects against suppression of growth by methotrexate in mice.
Topics: Animals; Antidotes; Body Weight; Eating; Folic Acid Antagonists; Growth Disorders; Intestine, Small; Kidney; Leucovorin; Liver; Male; Methotrexate; Mice; Mice, Inbred BALB C; Tetrahydrofolate Dehydrogenase | 2001 |
Winchester syndrome.
Topics: Abnormalities, Multiple; Arthritis; Child; Contracture; Corneal Diseases; Follow-Up Studies; Growth Disorders; Hand Deformities, Acquired; Humans; Infant; Male; Methotrexate; Orthopedic Procedures; Osteolysis, Essential; Radiography; Severity of Illness Index; Syndrome; Treatment Outcome | 2001 |
Recognition in adult patients of malformations induced by folic-acid antagonists.
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Adult; Aminopterin; Female; Growth Disorders; Humans; Male; Methotrexate; Orofaciodigital Syndromes; Phenotype; Syndrome | 1978 |
Analysis of growth failure in children treated for acute lymphoblastic leukemia.
Topics: Adolescent; Anthropometry; Antineoplastic Combined Chemotherapy Protocols; Body Height; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Growth Disorders; Humans; Incidence; Infant; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Puberty, Delayed; Radiation Injuries; Remission Induction; Risk Factors | 1992 |
Disturbed pubertal growth in girls treated for acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Body Height; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Female; Growth Disorders; Growth Hormone; Humans; Menarche; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Puberty; Vincristine | 1987 |
[Organ dysfunctions caused by cancer therapy in children].
Topics: Antineoplastic Agents; Bone Development; Child; Child, Preschool; Cyclophosphamide; Female; Growth Disorders; Heart; Humans; Infant; Leukemia, Lymphoid; Male; Methotrexate; Radiotherapy Dosage; Skull; Thyroid Gland; Thyrotropin; Thyroxine; Triiodothyronine | 1985 |
[The treatment of dermatomyositis].
Topics: Adolescent; Adrenocorticotropic Hormone; Alpha-Globulins; Antibodies, Antinuclear; Antimetabolites; Azathioprine; Blood Protein Electrophoresis; Calcinosis; Child; Creatine; Dermatomyositis; Electromyography; Exercise Therapy; Female; Fluorescent Antibody Technique; Fructose-Bisphosphate Aldolase; Growth Disorders; Humans; Immunosuppression Therapy; L-Lactate Dehydrogenase; Male; Mercaptopurine; Methotrexate; Middle Aged; Muscles; Prednisone; Remission, Spontaneous; Staphylococcal Infections; Transaminases | 1974 |